The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has ...

Researchers have developed a lung-targeted nanoparticle delivery system for genetic therapies. In a major step forward for ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...